Hiroyuki Yamaguchi

ORCID: 0000-0002-3754-6723 · 3 papers in corpus
2003
·doi:10.1007/978-4-431-53981-0_18
2003
other 2002
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.87.7.8682

Survivin is a novel inhibitor of apoptosis and is expressed during fetal development and in cancer tissues, but its expression has not been reported in normal adult tissues or benign diseases. We investigated survivin gene and protein expre…